Annual Retained Earnings
-$184.33 M
-$15.79 M-9.37%
December 31, 2023
Summary
- As of February 7, 2025, ENTO annual retained earnings is -$184.33 million, with the most recent change of -$15.79 million (-9.37%) on December 31, 2023.
- During the last 3 years, ENTO annual retained earnings has fallen by -$88.96 million (-93.29%).
- ENTO annual retained earnings is now -7693.70% below its all-time high of -$2.37 million, reached on December 1, 2014.
Performance
ENTO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$190.15 M
-$2.58 M-1.38%
September 1, 2024
Summary
- As of February 7, 2025, ENTO quarterly retained earnings is -$190.15 million, with the most recent change of -$2.58 million (-1.38%) on September 1, 2024.
- Over the past year, ENTO quarterly retained earnings has dropped by -$5.82 million (-3.16%).
- ENTO quarterly retained earnings is now -2192.23% below its all-time high of -$8.30 million, reached on December 1, 2015.
Performance
ENTO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ENTO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.4% | -3.2% |
| 3 y3 years | -93.3% | -10.2% |
| 5 y5 years | -287.9% | -209.6% |
ENTO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.8% | at low | -23.6% | at low |
| 5 y | 5-year | -194.0% | at low | -203.3% | at low |
| alltime | all time | -7693.7% | at low | -2192.2% | at low |
Entero Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$190.15 M(+1.4%) |
| Jun 2024 | - | -$187.57 M(+4.9%) |
| Mar 2024 | - | -$178.76 M(-3.0%) |
| Dec 2023 | -$184.33 M(+9.4%) | -$184.33 M(+2.3%) |
| Sep 2023 | - | -$180.23 M(+1.9%) |
| Jun 2023 | - | -$176.79 M(+2.4%) |
| Mar 2023 | - | -$172.60 M(+2.4%) |
| Dec 2022 | -$168.53 M(+9.5%) | - |
| Dec 2022 | - | -$168.53 M(+2.4%) |
| Sep 2022 | - | -$164.55 M(-2.6%) |
| Jun 2022 | - | -$168.94 M(+3.3%) |
| Mar 2022 | - | -$163.53 M(+6.3%) |
| Dec 2021 | -$153.90 M(+61.4%) | -$153.90 M(+7.8%) |
| Sep 2021 | - | -$142.73 M(+27.1%) |
| Jun 2021 | - | -$112.33 M(+9.0%) |
| Mar 2021 | - | -$103.05 M(+8.1%) |
| Dec 2020 | -$95.37 M | -$95.37 M(+22.3%) |
| Sep 2020 | - | -$77.97 M(+7.3%) |
| Jun 2020 | - | -$72.65 M(+6.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$67.96 M(+8.4%) |
| Dec 2019 | -$62.69 M(+31.9%) | -$62.69 M(+2.1%) |
| Sep 2019 | - | -$61.41 M(+7.3%) |
| Jun 2019 | - | -$57.22 M(+9.7%) |
| Mar 2019 | - | -$52.18 M(+9.8%) |
| Dec 2018 | -$47.52 M(+39.8%) | -$47.52 M(+9.2%) |
| Sep 2018 | - | -$43.50 M(+6.3%) |
| Jun 2018 | - | -$40.93 M(+8.8%) |
| Mar 2018 | - | -$37.62 M(+10.7%) |
| Dec 2017 | -$33.98 M(+48.5%) | -$33.98 M(+7.9%) |
| Sep 2017 | - | -$31.50 M(+11.0%) |
| Jun 2017 | - | -$28.37 M(+10.4%) |
| Mar 2017 | - | -$25.70 M(+12.3%) |
| Dec 2016 | -$22.89 M(+175.9%) | -$22.89 M(+32.6%) |
| Sep 2016 | - | -$17.26 M(+22.8%) |
| Jun 2016 | - | -$14.06 M(+36.7%) |
| Mar 2016 | - | -$10.29 M(+24.0%) |
| Dec 2015 | -$8.30 M(+250.7%) | -$8.30 M |
| Dec 2014 | -$2.37 M | - |
FAQ
- What is Entero Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Entero Therapeutics?
- What is Entero Therapeutics annual retained earnings year-on-year change?
- What is Entero Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Entero Therapeutics?
- What is Entero Therapeutics quarterly retained earnings year-on-year change?
What is Entero Therapeutics annual retained earnings?
The current annual retained earnings of ENTO is -$184.33 M
What is the all time high annual retained earnings for Entero Therapeutics?
Entero Therapeutics all-time high annual retained earnings is -$2.37 M
What is Entero Therapeutics annual retained earnings year-on-year change?
Over the past year, ENTO annual retained earnings has changed by -$15.79 M (-9.37%)
What is Entero Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ENTO is -$190.15 M
What is the all time high quarterly retained earnings for Entero Therapeutics?
Entero Therapeutics all-time high quarterly retained earnings is -$8.30 M
What is Entero Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ENTO quarterly retained earnings has changed by -$5.82 M (-3.16%)